首頁 > 市場調查報告書 > 醫療設備

心血管設備手術用器具

市場調查報告書

商品編碼

1319140

2023-2030 年全球氣霧劑貼片市場

Global Vacular Patches Market - 2023-2030

出版日期: 2023年07月31日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球血管系統市場規模在2022 年達到7 億美元，預計到2030 年將達到12 億美元，2023-2030 年的年複合成長率為7.6%。動脈瘤、動脈狹窄和不必要的血栓等疾病的流行等因素推動了預測期內的市場規模。由於老齡人口數量的增加，北美地區的市場規模也在不斷擴大，其主要競爭對手包括泰爾茂公司、CR Bard 公司、博朗梅爾松根公司等。

血管貼片用於周邊血管重建、表麵線支撐和其他修復。血管貼片由聚酯聚氨酯製成。補片中使用的彈性材料有助於減少縫合孔出血。

市場動態

慢性靜脈功能不全的增加將推動市場成長

推動血管貼片市場發展的主要因素是慢性靜脈功能不全病例數量的增加。許多人患有慢性靜脈功能不全，這導致了血管手術，從而推動了市場的成長。慢性靜脈功能不全的增加將推動市場成長，例如，發表在《Stats Pearls》上的一篇文章指出，慢性靜脈功能不全（CVI）通常指下肢水腫、皮膚營養性改變以及繼發於靜脈高壓的不適。慢性靜脈功能不全是一種常見疾病。

與慢性靜脈功能不全有關的殘疾會導致生活品質下降和工作效率降低。大多數情況下，病因是瓣膜功能不全。每年約有15 萬新患者被診斷為慢性靜脈功能不全，用於治療這些患者的費用將近5 億美元。因此，疾病的增加將推動市場成長。

主要企業的關鍵戰略將推動市場成長

主要企業關鍵戰略的興起將主導市場成長。例如，2022 年5 月19 日，總部位於愛爾蘭的血管閉合設備公司Vivasure 通過一系列投資籌集了約2500 萬美元，用於推進其可吸收貼片式經皮血管閉合技術的臨床開發和法規核准。 PerQseal "技術在血管內和心血管手術中使用，利用合成植入物從內部封閉靜脈或動脈。

其他現有解決方案會留下膠原蛋白、縫合線或金屬植入物等材料，而Vivasure 的合成植入物可使動脈或靜脈恢復正常狀態，不會留下任何殘留物。因此，主要企業的戰略有助於推動市場成長。

昂貴的血管手術費用將阻礙市場成長

由於血管手術費用昂貴，患者即使需要也無力承擔。例如，印度血管手術的平均費用為600 美元至800 美元不等，未經處理的自體心包的單位補片費用為5 美元，而同種移植分支補片的單位補片費用為6105 美元。因此，血管手術的高成本會阻礙市場成長。

COVID-19 影響分析

COVID-19 流行病對血管補片市場產生了重大影響，給許多國家帶來了前所未有的挑戰。由於COVID-19，外科手術急劇減少，手術被推遲。由於手術減少，血管貼片的使用也隨之減少。因此，這對血管貼片市場產生了負面影響。

俄烏戰爭影響分析

據估計，俄烏衝突對全球血管貼片市場的影響不大，因為該地區的主要市場參與者較少。不過，在預測期內，原料進出口對全球血管貼片市場成長的影響預計不大。

Market Overview

Global Vascular System Market reached US$ 0.7 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 7.6% during the forecast period 2023-2030. Factors such as the prevalence of diseases like aneurysms, arterial stenosis, and unwanted blood clots drives the market size in the forecast period. Due to the rise in the number of the aging population, the market is increasing in the North American region with significant competitors like Terumo Corporation, C R Bard Inc, B Braun Melsungen AG, and others.

Vascular patches are used for peripheral vascular reconstruction, surface line buttressing, and other repairs. The patches are also used for femoral, renal, and iliac endarterectomy procedures. vascular patches are made up of polyester urethane. The elastic material used in patches helps to reduce suture hole bleeding.

Market Dynamics

Rising Chronic Venous Insufficiency Will Drive the Market Growth

The major factor that is driving the vascular patches market is the increase in the number of chronic venous insufficiency cases. A number of people are suffering from chronic venous insufficiency, which is leading to vascular surgeries, and that is driving the growth of the market. Rising chronic venous insufficiency will drive market growth, for instance, an article published in Stats Pearls stated that Chronic venous insufficiency (CVI) typically refers to lower extremity edema, skin trophic changes, and discomfort secondary to venous hypertension. Chronic venous insufficiency is a prevalent disease.

Disability related to chronic venous insufficiency attributes to diminished quality of life and loss of work productivity. In most cases, the cause is incompetent valves. Each year approximately 150,000 new patients are diagnosed with chronic venous insufficiency, and nearly $500 million is used in the care of these patients. Thus the rise of diseases will drive the market growth.

Key Strategies by the Key Players will Drive the Market Growth

The rise of key strategies by the key players will dominate the market growth. For instance, on May 19, 2022, in a series of investments, Ireland-based vessel closure device firm Vivasure raised about $25 million to advance clinical development and regulatory approval for its absorbable, patch-based, percutaneous vessel-sealing technology. Utilized during endovascular and cardiovascular procedures, the "PerQseal" technology uses a synthetic implant to seal a vein or artery from the inside.

While other existing solutions leave behind materials such as collagen, sutures, or metal implants, Vivasure's synthetic implants were designed to return an artery or vein to its normal state without leaving any remnants behind. Thus the strategies of the key players help to drive the market growth.

Expensive Cost of Vascular Procedures will Hamper the Market Growth

Due to the expensive cost of vascular procedures, patients could not afford them even if required. For instance, the average cost of vascular surgery in India ranges from US$600-US$800, and the cost per unit patch ranges from $5 (dollars, US) for untreated autologous pericardium to $6,105 for homograft branch patch. Thus high cost of vascular procedures can hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a significant influence on the vascular patches market, posing unprecedented challenges to many countries. Due to COVID-19, there is a rapid decrease in surgical procedures, and the surgeries have been postponed. Due to the reduction insurgeries, the usage of vascular patches has been reduced. Thus, it has negatively impacted the vascular patch market.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global vascular patches market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global vascular patches market growth over the forecast period.

Segment Analysis

The global vascular patches market is segmented based on material type, application, and end user.

The Carotid Endarterectomy Segment Holds the Dominant Position in the Market Over Forecast Period with 56.4% share.

Carotid Endarterectomyholds the most significant market share.Carotid endarterectomy is a surgical procedure to remove a build-up of fatty deposits (plaque), which cause the narrowing of a carotid artery. The carotid arteries are the main blood vessels that supply blood to the neck, face, and brain.

Carotid endarterectomy (CEA) is among the most frequently performed vascular operations in the United States. For instance, according to the Journal of Vascular Surgeries, more than 100,000 such operations are performed annually at a cost of $1.2 billion. Thus increase in the number of carotid endarterectomy surgeries is holding the carotid endarterectomy in the top position.

Geographical Analysis

Asia Pacific Accounted for 23.7% of the Market Share Owing to the Prevalence of Diseases

Due to the increasing penetration of commercial providers in this region and the expanding launch of plans by central and state governments. Furthermore, the rising frequency of chronic diseases and densely populated nations such as China and India would drive market expansion in the vascular patches market.

Cardiovascular diseases (CVDs), the world's leading cause of death, claim as many as 17.9 million lives each year globally. According to a study by the Indian Council of Medical Research and Registrar General of India, India accounts for approximately 60 percent of the world's heart disease burden.

Competitive Landscape

The major global players in the global vascular patches market include: Becton, Dickinson and Company; Terumo Corporation; C R Bard, Inc; B Braun MelsungenAG; LeMaitre Vascular, Inc; Admedus; CryoLife, Inc; LabcorLaboratorios Ltd; Baxter International IncScience among others.

Why Purchase the Report?

To visualize the global vascular patches market segmentation based on material type, application, end-user, and region,as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global vascular patches market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global vascular patches market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Material Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rise in the prevalence of vascular diseases
  - 4.1.1.2. An increase in the number of elderly aging people
- 4.1.2. Restraints
  - 4.1.2.1. Lack of skilled individuals
- 4.1.3. Opportunity
  - 4.1.3.1. Developments in the treatment methods
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario before COVID-19
- 6.1.2. Scenario during COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Material Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
- 8.1.2. Market Attractiveness Index, By Material Type
8.2. Autologous vein
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Bovine pericardium
8.4. Synthetic
- 8.4.1. Polytetrafluoroethylene (PTFE)
- 8.4.2. Dacron

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Carotid endarterectomy
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Vascular bypass surgery
9.4. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.6.1. The U.S.
  - 11.2.6.2. Canada
  - 11.2.6.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.6.1. Germany
  - 11.3.6.2. The U.K.
  - 11.3.6.3. France
  - 11.3.6.4. Italy
  - 11.3.6.5. Spain
  - 11.3.6.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.6.1. Brazil
  - 11.4.6.2. Argentina
  - 11.4.6.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.6.1. China
  - 11.5.6.2. India
  - 11.5.6.3. Japan
  - 11.5.6.4. Australia
  - 11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Becton Dickinson and Company
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Terumo Corporation
13.3. C R Bard, Inc
13.4. B Braun MelsungenAG
13.5. LeMaitre Vascular, Inc
13.6. Admedus, CryoLife, Inc
13.7. Labcor Laboratorios Ltd
13.8. Baxter International IncScience.
13.9. W.L. Gore&Associates, Inc
13.10. Vascudyne, Inc.

LIST NOT EXHAUSTIVE